• Consolidation boosts production efficiencies and establishes cost leadership for household care products
  • Better aligns production and innovation resources to further accelerate growth
  • Supports the transformation of Evonik Care Solutions into a wide specialty technology player
  • Manufacturing site in Granollers, Spain to close, with agreements reached with the employee representatives for all of the site’s 51 employees

Evonik will this month complete the consolidation of its European manufacturing activities for fabric softener ingredients to its world-class production sites in Steinau, Germany and Shanghai, China, and subsequently close its Granollers site near Barcelona in Spain.

Evonik’s Care Solutions business line is part of the Evonik growth division Nutrition & Care. Following a series of strategic acquisitions and inhouse innovations in recent years, the business line is transforming itself into a wide specialty technology leader. It is now strongly positioned to serve as a preferred supplier and development partner to help customers address the functional, convenience and sustainability needs of consumers.

“Together, Evonik’s Care Solutions people continue the successful transformation of the business by improving the asset network and cost position while investing further in innovation for better sustainable ingredients, as demonstrated with the recent launches of our rhamnolipid biosurfactant”, said Yann d'Hervé, head of Evonik's Care Solutions business line.

As part of the consolidation, which was first announced in 2018, Evonik will terminate production at its Granollers site near Barcelona in Spain this month. In a reflection of Evonik’s commitment to social responsibility, the company has reached an agreement with the employee representatives for all of the site’s 51 employees.

Company information 
Evonik is one of the world leaders in specialty chemicals. The company is active in more than 100 countries around the world and generated sales of €13.1 billion and an operating profit (adjusted EBITDA) of €2.15 billion in 2019. Evonik goes far beyond chemistry to create innovative, profitable and sustainable solutions for customers. More than 32,000 employees work together for a common purpose: We want to improve life, today and tomorrow.
About Nutrition & Care
The focus of the business of the Nutrition & Care division is on health and quality of life. It develops differentiated solutions for active pharmaceutical ingredients, medical devices, nutrition for humans and animals, personal care, cosmetics, and household cleaning. In these resilient end markets, the division generated sales of around €2.92 billion in 2019 with about 5,300 employees. It is part of Evonik Operations GmbH.


Back to top

We use cookies on our website. Some of them are essential for the operation of the site, while others help us to improve this site and the user experience (tracking cookies). You can decide for yourself whether you want to allow cookies or not. Please note that if you reject them, you may not be able to use all the functionalities of the site.